Results 221 to 230 of about 7,409,236 (309)

AI revolution in insurance: bridging research and reality. [PDF]

open access: yesFront Artif Intell
Bhattacharya S   +3 more
europepmc   +1 more source

A single‐centre analysis of a biosimilar switching programme for adalimumab in inflammatory bowel disease

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims Amgevita is a licensed biosimilar to adalimumab, having demonstrated high pharmacokinetic and clinical similarity to Humira. Switching to a lower‐cost medicine may elicit a nocebo effect, whereby expectations of poorer efficacy impact outcomes despite pharmacological similarity. This prospective cohort study examined clinical and economic outcomes
Louise Rabbitt   +7 more
wiley   +1 more source

Choice and diversity in governance in the English alternative provision sector: Implications for educational equity

open access: yesBritish Educational Research Journal, EarlyView.
Abstract Despite the continued global prevalence of discourses of educational inclusion, young people across local, national and international contexts continue to be educated outside of mainstream schools. In England, a diverse market of providers—known as alternative provision (AP)—cater for many of these young people.
Jodie Pennacchia   +3 more
wiley   +1 more source

Unlocking access: a comprehensive analysis of medicines accessibility for rare diseases in Thailand. [PDF]

open access: yesOrphanet J Rare Dis
Suwattanapreeda S   +6 more
europepmc   +1 more source

Does Climate Change Risk Impact Insurance Credit Risk? Cross Country Evidence

open access: yesBusiness Strategy and the Environment, EarlyView.
ABSTRACT While climate change poses a significant financial risk to the insurance industry, research has not yet examined the impact on the insurer's credit risk. This study investigates the impact of climate change risks on credit risk for insurance firms.
Jassem Alokla   +2 more
wiley   +1 more source

Sustainability Performance and Its Impact on Financial Distress Risk—Evidence From STOXX Europe 600

open access: yesBusiness Strategy and the Environment, EarlyView.
ABSTRACT Sustainability performance (SP) has emerged as a central topic on both corporate and political agendas worldwide. This study investigated the relationship between SP and financial distress risk (FDR) among European listed firms, addressing the growing importance of SP in financial decision‐making.
Marcel Seefloth   +4 more
wiley   +1 more source

ESG Disclosure and Access to Credit: A Configurational Analysis of European Listed Firms

open access: yesBusiness Strategy and the Environment, EarlyView.
ABSTRACT This study investigates how various ESG disclosure configurations affect credit access for European firms listed on the STOXX Europe 600 Index during 2021–2022. Employing fuzzy‐set qualitative comparative analysis and ESG disclosures standardised under the Global Reporting Initiative (GRI), the findings demonstrate that disclosure patterns ...
Carmen Gallucci   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy